Functional characterization of hepatitis B virus X protein based on the inhibition of tumorigenesis in nude mice injected with CCL13-HBx cells

Intervirology

Volumn 51, Issue 4, 2008, Pages 253-260

  Kuo, Chan Yen ^a   Wang, Jing Chyi ^a   Hsu, Shih Lan ^a   Hwang, Guang Yuh ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; HBx; Inhibition of tumorigenesis; Myosin light chain

Indexed keywords

ALPHA FETOPROTEIN ANTIBODY; CASPASE 3; CASPASE 8; MYOSIN LIGHT CHAIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS PROTEIN; X PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; DNA FRAGMENTATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEPATITIS B VIRUS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MONOCYTE CHEMOATTRACTANT PROTEINS; MYOSIN LIGHT CHAINS; TRANS-ACTIVATORS;

ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 52549106111     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000158522     Document Type: Article

References (55)

1. Zhang X, Zhang H, Ye L: Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006;147:58-66.
2. Iino S: Natural history of hepatitis B and C virus infections. Oncology 2002;62(suppl 1):18-23.
3. Murakami S: Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001;36:651-660.
4. Murakami S: Hepatitis B virus X protein: structure, function and biology. Intervirology 1999;42:81-99.
5. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G: Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol 1996;70:641-646.
6. Waris G, Huh KW, Siddiqui A: Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001;21:7721-7730.
7. Lee YI, Kang-Park S, Do SI, Lee YI: The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 2001;276:16969-16977.
8. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C: Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999;18:4848-4859.
9. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, Levrero M: The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997;94:8162-8167.
10. Kim H, Lee H, Yun Y: X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998;273:381-385.
11. Kuo CY, Wang JC, Wu CC, Hsu SL, Hwang GY: Effects of hepatitis B virus x protein (HBx) on cell-growth inhibition in a CCL13-HBx stable cell line. Intervirology 2008;51:26-32.
12. Miao J, Chen GG, Chun SY, Lai PP: Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett 2006;236:115-124.
13. Pollicino T, Terradillos O, Lecoeur H, Gougeon ML, Buendia MA: Pro-apoptotic effects of the hepatitis B virus X gene. Biomed Pharmacother 1998;52:363-368.
14. Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Kanegae Y, Kimura S, Saito I, Koike K: Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. J Gen Virol 1999;80:3257-3265.
15. Su F, Schneider RJ: Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744-8749.
16. Su F, Theodosis CN, Schneider RJ: Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol 2001;75:215-225.
17. Tanaka Y, Kanai F, Kawakami T, Tateishi K, Ijichi H, Kawabe T, Arakawa Y, Kawakami T, Nishimura T, Shirakata Y, Koike K, Omata M: Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis. Biochem Biophys Res Commun 2004;318:461-469.
18. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA: p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998;17:2115-2123.
19. Yang Y, Zheng L, Lv G, Jin X, Sheng J: Hepatocytes treated with HBV X protein as cytotoxic effectors kill primary hepatocytes by TNF-alpha-related apoptosis-induced ligand-mediated mechanism. Intervirology 2007;50:323-327.
20. Madden CR, Slagle BL: Stimulation of cellular proliferation by hepatitis B virus X protein. Dis Markers 2001;17:153-157.
21. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL: Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem 2000;275:25858-25864.
22. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL: Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase. J Biol Chem 2003;278:31807-31813.
23. Hwang GY, Lin CY, Huang LM, Wang YH, Wang JC, Hsu CT, Yang SS, Wu CC: Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Clin Microbiol 2003;41:5598-5603.
24. Wang JC, Hsu SL, Hwang GY: Inhibition of tumorigenicity of the hepatitis B virus X gene in Chang liver cell line. Virus Res 2004;102:133-139.
25. Chignard N, Beretta L: Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology 2004;127(5 suppl 1):S120-S125.
26. Lee MF, Chen YH, Lin HC, Wang HL, Hwang GY, Wu CH: Identification of hevamine and hev B 1 as major latex allergens in Taiwan. Int Arch Allergy Immunol 2006;139:38-44.
27. Kojiro M: Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 2004;10(2 suppl 1):S3-S8.
28. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP: Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 2007;43:979-992.
29. Suzuki T, Yano H, Nakashima Y, Nakashima O, Kojiro M: Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process. J Gastroenterol Hepatol 2002;17:994-1000.
30. Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT: Biology of hepatocellular carcinoma. Ann Surg Oncol 2008;15:962-971.
31. Yao DF, Dong ZZ, Yao M: Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2007;6:241-247.
32. Fabregat I, Roncero C, Fernández M: Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int 2007;27:155-162.
33. Akbar SM, Horiike N, Onji M, Hino O: Dendritic cells and chronic hepatitis virus carriers. Intervirology 2001;44:199-208.
34. Feitelson MA: Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol 1999;181:188-202.
35. Schuster R, Gerlich WH, Schaefer S: Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 2000;19:1173-1180.
36. Lau JY, Xie X, Lai MM, Wu PC: Apoptosis and viral hepatitis. Semin Liver Dis 1998;18:169-176.
37. Shin EC, Shin JS, Park JH, Kim H, Kim SJ: Expression of fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBX) in induction of Fas ligand. Int J Cancer 1999;82:587-591.
38. Yoo YD, Ueda H, Park K, Flanders KC, Lee YI, Jay G, Kim SJ: Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator: role in HBV pathogenesis. J Clin Invest 1996;97:388-395.
39. Arbuthnot P, Capovilla A, Kew M: Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 2000;15:357-368.
40. Feitelson MA: Products of the 'X' gene in hepatitis B and related viruses. Hepatology 1986;6:191-198.
41. Moriarty AM, Alexander H, Lerner RA, Thornton GB: Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 1985;227:429-433.
42. Paterlini P, Poussin K, Kew M, Franco D, Brechot C: Selective accumulation of the X-transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313-321.
43. Wang WL, London WT, Feitelson MA: Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 1991;51:4971-4977.
44. Kuo CY, Wu CC, Hsu SL, Hwang GY: HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3beta/beta-catenin cascade. Intervirology 2008;51:130-136.
45. Chan DW, Ng IO: Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. J Pathol 2006;208:372-380.
46. Feitelson MA, Clayton MM, Sun B, Schinazi RF: Development of a novel mouse model to evaluate drug candidates against hepatitis B virus. Antivir Chem Chemother 2007;18:213-223.
47. Hsu SL, Lin HM, Chou CK: Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment. Cancer Lett 1996;99:79-85.
48. Lu JJ, Lay JD: Tumor formation in nude mice inoculated with cultured human epithelial cells co-expressing Epstein-Barr virus latent membrane protein 1 and Bcl-2. Intervirology 2007;50:454-460.
49. Wei W, Huang W, Pan Y, Zhu F, Wu J: Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras. Cancer Lett 2006;244:119-128.
50. Eddinger TJ, Meer DP: Myosin II isoforms in smooth muscle: heterogeneity and function. Am J Physiol Cell Physiol 2007;293:C493-C508.
51. Clark K, Langeslag M, Figdor CG, van Leeuwen FN: Myosin II and mechanotransduction: a balancing act. Trends Cell Biol 2007;17:178-186.
52. Lincoln TM: Myosin phosphatase regulatory pathways: different functions or redundant functions? Circ Res 2007;100:10-12.
53. Sebbagh M, Renvoizé C, Hamelin J, Riché N, Bertoglio J, Bréard J: Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 2001;3:346-352.
54. Petrache I, Birukov K, Zaiman AL, Crow MT, Deng H, Wadgaonkar R, Romer LH, Garcia JG: Caspase-dependent cleavage of myosin light chain kinase (MLCK) is involved in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. FASEB J 2003;17:407-416.
55. Wadgaonkar R, Nurmukhambetova S, Zaiman AL, Garcia JG: Mutation analysis of the non-muscle myosin light chain kinase (MLCK) deletion constructs on CV1 fibroblast contractile activity and proliferation. J Cell Biochem 2003;88:623-634.